In Vitro Exposure by VR to Enhance Return to Work After Sick Leave Due to Mental Health Related Complaints

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

About this trial

The goal of this pilot randomised controlled trial is to investigate whether in vitro exposure by VR enhances return to work (RTW) in flight cabin crew on sick leave with mental health related complaints. The main research questions are: 1. Does VR enhances time to RTW? 2. Does VR increase self-efficacy and positive cognitions regarding RTW, and decrease job anxiety? Researchers will compare a control group receiving care as usual as provided by the occupational physician and a psychologist to an intervention group receiving care as usual plus (al least) one session with VR-glasses in which participants are virtually exposed to their workplace.

Eligibility criteria

Qualifiers

None

Disqualifiers

epilepsy

vestibular disorder

no signed informed consent

Trial design

Treatments tested in this trial

  • In vitro exposure to workplace by VR plus care as usual
  • Care as usual: Guidance from occupational physician and psychologist focused on returning to work

Treatment groups

118 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Lead sponsor

KLM Royal Dutch Airlines

Collaborator

KLM Health Services

Collaborator

Villa Uitzicht

Collaborator